US BioTec, Inc. (USBC)
- Previous Close
0.0001 - Open
0.0001 - Bid --
- Ask --
- Day's Range
0.0001 - 0.0001 - 52 Week Range
0.0001 - 0.0002 - Volume
17 - Avg. Volume
12 - Market Cap (intraday)
-- - Beta (5Y Monthly) 1,289.68
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
US BioTec, Inc. engages in the development, manufacture, marketing, and distribution of bio-degradable, nontoxic, and noncarcinogenic products in the United States. Its product portfolio consists of approximately 30 products, which stimulate plants that produce crops; correct microbial and mineral problems present in soils; and rehabilitate the soil ecosystem by breaking down the residual build-up of toxic insecticides, herbicides, fungicides, and synthetic fertilizers. The company provides its products for agriculture, commercial turf industry, forestry, golf courses, professional landscapers, nurseries and mass market retail lawn, and garden markets. US BioTec, Inc. is based in Gleason, Tennessee.
--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: USBC
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: USBC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: USBC
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-23.01%
Return on Assets (ttm)
-25.55%
Return on Equity (ttm)
-204.34%
Revenue (ttm)
1.64M
Net Income Avi to Common (ttm)
-376.31k
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
33.07k
Total Debt/Equity (mrq)
134.06%
Levered Free Cash Flow (ttm)
--
Company Insights: USBC
USBC does not have Company Insights